We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$91.7B
AUM Growth
+$307M
Cap. Flow
-$3.9B
Cap. Flow %
-4.25%
Top 10 Hldgs %
9.09%
Holding
3,750
New
412
Increased
1,673
Reduced
1,111
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$693M
2
META icon
Meta Platforms (Facebook)
META
+$446M
3
JNJ icon
Johnson & Johnson
JNJ
+$306M
4
EVRG icon
Evergy
EVRG
+$288M
5
WMT icon
Walmart Inc
WMT
+$265M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$596M
2
BKNG icon
Booking.com
BKNG
+$519M
3
AMZN icon
Amazon
AMZN
+$518M
4
LLY icon
Eli Lilly
LLY
+$268M
5
UNH icon
UnitedHealth
UNH
+$246M

Sector Composition

Rank Sector Weight
1 Healthcare 17.51%
2 Technology 14.39%
3 Financials 11.76%
4 Consumer Discretionary 9.46%
5 Real Estate 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEN
2951
DELISTED
Apollo Endosurgery, Inc.
APEN
$316K ﹤0.01%
45,300
+10,700
+31% +$66.5K
BIO.B icon
2952
Bio-Rad Laboratories Class B
BIO.B
$314K ﹤0.01%
1,100
PXLW icon
2953
Pixelworks
PXLW
$42.3M
$311K ﹤0.01%
7,171
-53,872
-88% -$2.64M
XMLV icon
2954
Invesco S&P MidCap Low Volatility ETF
XMLV
$743M
$310K ﹤0.01%
6,600
-6,400
-49% -$293K
VOC icon
2955
VOC Energy
VOC
$53M
$309K ﹤0.01%
58,200
-10,330
-15% -$52.1K
ENBL
2956
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$308K ﹤0.01%
18,000
-351,700
-95% -$5.37M
IWO icon
2957
iShares Russell 2000 Growth ETF
IWO
$15B
$306K ﹤0.01%
+1,500
New +$300K
MTL.PR
2958
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$303K ﹤0.01%
299,600
+6,800
+2% +$6.95K
JMP
2959
DELISTED
JMP Group LLC
JMP
$301K ﹤0.01%
55,964
-10,016
-15% -$51.3K
LCTX icon
2960
Lineage Cell Therapeutics
LCTX
$278M
$300K ﹤0.01%
166,421
-721,004
-81% -$1.45M
SCHX icon
2961
Schwab US Large- Cap ETF
SCHX
$74.5B
$299K ﹤0.01%
+27,600
New +$298K
HK
2962
DELISTED
Halcon Resources Corporation
HK
$299K ﹤0.01%
68,000
-1,402,389
-95% -$6.8M
CLS icon
2963
Celestica
CLS
$42.8B
$298K ﹤0.01%
+25,100
New +$288K
IOO icon
2964
iShares Global 100 ETF
IOO
$9.43B
$298K ﹤0.01%
6,500
+500
+8% +$23.3K
SNDX icon
2965
Syndax Pharmaceuticals
SNDX
$1.77B
$297K ﹤0.01%
42,300
-10,200
-19% -$100K
MYOV
2966
DELISTED
Myovant Sciences Ltd.
MYOV
$297K ﹤0.01%
+13,000
New +$284K
PBBI
2967
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$297K ﹤0.01%
26,183
+10,283
+65% +$109K
BPTH
2968
DELISTED
Bio-Path Holdings Inc
BPTH
$296K ﹤0.01%
497
+155
+45% +$108K
MAMS
2969
DELISTED
MAM Software Group Inc. New
MAMS
$296K ﹤0.01%
+34,300
New +$285K
LFCR icon
2970
Lifecore Biomedical
LFCR
$181M
$295K ﹤0.01%
+19,800
New +$275K
AFMD
2971
DELISTED
Affimed
AFMD
$293K ﹤0.01%
17,751
+4,961
+39% +$105K
USDP
2972
DELISTED
USD PARTNERS LP
USDP
$292K ﹤0.01%
+27,200
New +$296K
KALV
2973
DELISTED
KalVista Pharmaceuticals
KALV
$290K ﹤0.01%
35,728
-7,700
-18% -$68K
KTCC icon
2974
Key Tronic
KTCC
$41.9M
$290K ﹤0.01%
38,300
-5,968
-13% -$46.4K
ROG icon
2975
Rogers Corp
ROG
$2.48B
$290K ﹤0.01%
2,600
-94,600
-97% -$11M

Similar funds

Jim Simons's Q2 2018 Portfolio in Review

As of Q2 2018, Jim Simons held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Jim Simons withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Jim Simons opened a new position in Apple worth $707M.

  • Jim Simons's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
  • Jim Simons added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
  • Jim Simons's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
  • Jim Simons fully exited Booking.com in Q2 2018, selling an estimated $519M.
  • Jim Simons's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
  • Jim Simons opened 412 new positions and closed 524 in Q2 2018.
  • Jim Simons's portfolio value rose 0.34% quarter-over-quarter to $91.7B.

Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.